United Kingdom
Licensed manufacturer and wholesale channels, subject to product, supplier and export-route checks.
MBH Pharma Limited · Accra
Pharmaceutical sourcing for Ghana.
Connecting global healthcare to Ghana through requirement-led medicine sourcing, named-patient access coordination and time-sensitive delivery planning for eligible organisations.
Priority intakeNamed-patient·Shortage·Institutional requirements
Air access / Accra05.56° N
DOCUMENT-LED·TEMPERATURE-AWARE→ACCRA
Verified local recordGhana FDA public storage-facility record
- Licence
- FDA/DID/GSDP/044/26
- Category
- Finished pharmaceutical products
- Valid until
- 06 April 2027
Patient-specific access
Named-patient access, coordinated around the exact case.
When a treating clinician identifies a patient-specific need that registered and available options may not meet, MBH Pharma can help an eligible healthcare organisation coordinate the product, source, documents and delivery questions.
- 01Clinician-led requirement
The treating clinician or eligible institution defines the exact product need.
- 02Pathway and document review
Registration status, source information and the applicable Ghana FDA route are clarified.
- 03Source and delivery coordination
Supplier confirmation, product documents, storage and air-route requirements are aligned before movement.
Ghana FDA’s published named-patient procedure specifically covers unregistered biological products, including vaccines. Other medicines may require a different pathway. MBH Pharma does not prescribe or grant regulatory permission. Do not include patient-identifiable information in an initial enquiry.
Global sourcing network
Established source markets. Coordinated into Ghana.
Eligible medicines are sourced through appropriately licensed partners in the United Kingdom, European Union/EEA and United States. Every route remains subject to the exact product, supplier and export requirements.
Source-market contextReviewed for each exact requirement → ACCRA
European Union & EEA
Authorised market participants reviewed against the relevant European or national authority record.
United States
Authorised trading channels reviewed for wholesale status, product identity and supply-chain traceability.
What we do
Access, sourcing, documentation and delivery planning.
Each enquiry starts with the exact medicine, clinical or institutional context, requesting organisation and destination. Availability and route options are assessed from those details.
View service scopeNamed-patient access coordination
Clinician-led, patient-specific enquiry support for product, source, documentation and delivery requirements.
Institutional supply enquiries
A structured starting point for hospitals, pharmacies and eligible healthcare organisations with a defined product requirement.
Specialty & shortage enquiries
Focused coordination for hard-to-source, specialty and time-sensitive medicine requirements.
Delivery & cold-chain planning
Route, handover and temperature-requirement planning shaped around the exact product and destination.
Tender & documentation support
Requirement clarification and document coordination for institutional procurement and tender-related enquiries.
A visible process
A complete brief lets urgent work start sooner.
Priority is based on clinical or institutional need and the completeness of the requirement. Capability, timing and availability remain conditional until confirmed.
Priority intake: named-patient, shortage, critical-care and other time-sensitive professional requirements.
- 01
What you send
Product or INN, strength, form, pack, quantity, destination, target date and storage need.
- 02
What MBH checks
Product identity, potential authorised source, supplier evidence, route and temperature requirements.
- 03
What the pathway needs
Clinician or institution details, applicable permits, product documents, labels and agreed responsibilities.
- 04
What happens next
A feasible route is confirmed before any commercial or transport commitment is made.
MBH Pharma · Accra
Ghana-based coordination for international supply.
Medicine access depends on precise product information, realistic timing, suitable storage and coordinated decisions between organisations. MBH Pharma exists to make that work more manageable.
- Based in
- Accra, Ghana
- Primary markets
- UK · EU/EEA · USA
- Enquiries
- Institutional and professional
Professional enquiries
Tell us what medicine you need.
Share the product details you already have. Your email application will open with a structured request ready to review and send.
- Product / INN, strength, form and pack
- Quantity, destination and target date
- Storage or temperature requirement
- Requirement type and requesting institution